Enkai Cell Technology Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
60
- Latest Deal Type
-
Series A3
- Latest Deal Amount
-
$13.9M
- Investors
-
11
Enkai Cell Technology General Information
Description
Researcher of immune cell drugs designed for tumour patients. The company focuses on applying synthetic immunology technology to NK (Natural Killer) cells to artificially create various NK cells that meet different clinical needs, enabling tumour patients to get efficient treatment with fewer side effects.
Contact Information
Website
nk-celltech.comCorporate Office
- Building 7, Lane 100, Banxia Road
- Zhoupu Town, Pudong New Area
- Shanghai, 200120
- China
Corporate Office
- Building 7, Lane 100, Banxia Road
- Zhoupu Town, Pudong New Area
- Shanghai, 200120
- China
Enkai Cell Technology Timeline
Enkai Cell Technology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series A3) | 09-Jul-2025 | $13.9M | Completed | Generating Revenue | ||
| 5. Early Stage VC (Series A2) | 22-Nov-2024 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 03-Jun-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 30-Jun-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 19-Nov-2021 | Completed | Generating Revenue | |||
| 1. Corporate | 23-Apr-2021 | Completed | Generating Revenue |
Enkai Cell Technology Comparisons
Industry
Financing
Details
Enkai Cell Technology Competitors (2)
One of Enkai Cell Technology’s 2 competitors is Nkarta Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nkarta Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Fate Therapeutics | Formerly VC-backed | San Diego, CA |
Enkai Cell Technology Signals
Enkai Cell Technology Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3Sbio | Corporation | Minority | ||
| Yijin Capital | Venture Capital | Minority | ||
| Beijing FOF Capital | Growth/Expansion | Minority | ||
| Gandao Investment Holding Company | Asset Manager | Minority | ||
| Huagai Capital | Venture Capital | Minority |
Enkai Cell Technology FAQs
-
When was Enkai Cell Technology founded?
Enkai Cell Technology was founded in 2020.
-
Where is Enkai Cell Technology headquartered?
Enkai Cell Technology is headquartered in Shanghai, China.
-
What is the size of Enkai Cell Technology?
Enkai Cell Technology has 60 total employees.
-
What industry is Enkai Cell Technology in?
Enkai Cell Technology’s primary industry is Drug Discovery.
-
Is Enkai Cell Technology a private or public company?
Enkai Cell Technology is a Private company.
-
What is Enkai Cell Technology’s current revenue?
The current revenue for Enkai Cell Technology is .
-
How much funding has Enkai Cell Technology raised over time?
Enkai Cell Technology has raised $28.9M.
-
Who are Enkai Cell Technology’s investors?
3Sbio, Yijin Capital, Beijing FOF Capital, Gandao Investment Holding Company, and Huagai Capital are 5 of 11 investors who have invested in Enkai Cell Technology.
-
Who are Enkai Cell Technology’s competitors?
Nkarta Therapeutics and Fate Therapeutics are competitors of Enkai Cell Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process